Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.02B | 2.32B | 1.62B | 1.37B | 925.37M |
Gross Profit | 909.35M | 700.00M | 499.54M | 620.30M | 437.49M |
EBITDA | 375.05M | 429.90M | 324.22M | -62.75M | 119.11M |
Net Income | 306.78M | 252.20M | 180.85M | -507.07M | -255.75M |
Balance Sheet | |||||
Total Assets | 3.66B | 3.38B | 2.61B | 2.39B | 1.45B |
Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.33B | 1.02B | 1.03B | 357.33M |
Total Debt | 508.56M | 370.57M | 351.29M | 345.37M | 870.46M |
Total Liabilities | 1.28B | 1.07B | 891.49M | 842.39M | 2.58B |
Stockholders Equity | 2.38B | 2.30B | 1.72B | 1.55B | -1.13B |
Cash Flow | |||||
Free Cash Flow | 361.77M | 332.41M | 244.02M | 138.03M | 136.31M |
Operating Cash Flow | 452.37M | 410.14M | 281.00M | 187.75M | 154.90M |
Investing Cash Flow | -267.37M | -263.61M | -178.36M | -48.95M | -117.47M |
Financing Cash Flow | -375.19M | 157.50M | -138.08M | 638.57M | 76.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | 8.64B | 29.41 | 24.18% | 1.42% | 28.53% | 22.34% | |
70 Outperform | 712.26M | 8.63 | 1.07% | 7.51% | 0.47% | 50.46% | |
68 Neutral | 1.67B | 5.75 | 22.09% | 4.29% | -3.56% | -17.45% | |
66 Neutral | HK$7.85B | 21.09 | 14.86% | 2.29% | 16.41% | 32.97% | |
65 Neutral | 9.12B | 18.56 | 8.99% | ― | -13.92% | -36.32% | |
54 Neutral | 1.79B | -12.50 | -6.84% | 0.45% | -0.55% | 45.36% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Gushengtang Holdings Limited reported a strong financial performance for the first half of 2025, with a 9.5% increase in revenue to RMB1,494.9 million compared to the same period in 2024. The company also saw significant growth in gross profit, EBITDA, and net profit, with increases of 14.1%, 37.3%, and 41.6% respectively. This robust performance highlights the company’s effective operational strategies and its positive positioning within the industry, potentially benefiting stakeholders and enhancing its market presence.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$48.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited has established a Nomination Committee to enhance its governance framework. This committee is tasked with identifying and recommending candidates for the board of directors, overseeing board performance evaluations, and developing nomination guidelines. The committee will consist of at least three members, with a majority being independent non-executive directors, ensuring diverse and independent oversight. This move is expected to strengthen the company’s board governance and align with the listing requirements of the Hong Kong Stock Exchange.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$48.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited has announced a voluntary share repurchase under a mandate approved by shareholders, allowing the company to buy back up to 23,696,549 shares, which is 10% of its total shares. This move, funded by internal resources, aims to enhance shareholder value and demonstrate confidence in the company’s long-term prospects, while maintaining sufficient financial resources for business growth.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$48.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited, incorporated in the Cayman Islands, has announced that its Board of Directors will convene on August 29, 2025, to review and approve the company’s unaudited interim results for the first half of the year and to consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting stakeholders’ expectations and the company’s market positioning.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited has announced a positive profit alert for the first half of 2025, expecting significant increases in revenue and net profit compared to the previous year. This growth is attributed to a rise in customer visits to its medical institutions, driven by the brand’s recognition and business expansion efforts. The company highlights the importance of its adjusted net profit metric, which excludes non-operating items, to provide a clearer picture of its operational performance.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited announced the successful passing of all proposed resolutions during its Annual General Meeting held on June 20, 2025. The resolutions included the adoption of the audited financial statements for the year ended December 31, 2024, the re-election of certain directors, and the declaration of a final dividend of HK$0.41 per share. The meeting saw full participation from shareholders, with no abstentions or votes against the resolutions, indicating strong shareholder support and confidence in the company’s governance and future plans.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The company has also established three committees: the Audit Committee, the Remuneration Committee, and the Nomination Committee, with specific directors assigned to each. This announcement provides clarity on the governance structure of the company, potentially impacting its decision-making processes and strategic direction.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.